Cresco Labs (CSE:CL) issued its financial results for the third quarter and nine month period ended on September 30.

As quoted in the press release:


Financial Results for the Third Quarter Ended September 30, 2018

Revenue for the third quarter of 2018 was [US]$12.2 million, an increase of 335 [percent] compared to revenue of [US]$2.8 million for the third quarter of 2017. The increase in revenue was driven by market expansion and gains in market share in the states where the Company operates. Third quarter revenue increased 51 [percent] compared to [US]$8.1 million for the second quarter of 2018.

On a pro forma basis, revenue for the third quarter was [US]$16.3 million compared to [US]$11.8 million for the second quarter of 2018, an increase of 39 [percent].

Third quarter gross profit, before the gain from biological assets, was [US]$5.4 million, or 45 [percent] of revenues, compared to less than [US]$0.1 million, or 1 [percent] of revenues, for the third quarter of 2017 and [US]$3.5 million, or 43 [percent] of revenues, for the second quarter of 2018.

Net income for the third quarter was $3.9 million, compared to net loss of [US]$0.2 million for the prior-year period. Net income nearly doubled from [US]$2.0 million for the second quarter of 2018.

Click here to read the full press release.

Source: www.businesswire.com

 Matica Enterprises Inc. (CSE: MMJ) (OTCQB: MMJFF) (FSE: 39N) (“Matica” or the “Company”) reports the Company has granted 6,500,000 stock options exercisable at $0.05 for five years from date of grant. These include 4,000,000 options to two officers (who are also directors) and, 2,500,000 to two consultants.

For more information on Matica Enterprises please visit the website at: www.maticaenterprises.com.

Keep reading... Show less

The Company welcomes adult-use customers at its eight dispensaries across the state and will create 120 new jobs in surrounding communities

– Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced it will begin serving adult-use consumers across its eight dispensaries in Arizona .

Keep reading... Show less

Harvest Health & Recreation Inc. (“Harvest”) (CSE: HARV, OTCQX: HRVSF), a vertically integrated cannabis company and multi-state operator in the U.S., today announced the launch of recreational cannabis sales in Arizona .

Keep reading... Show less

Jason Mitchell Co-Founder, Director and Chief Executive Officer, HempFusion Wellness Inc. (“HempFusion” or the “Company”) (TSX: CBD.U), and his team joined David Chelich Sector Head, Global Energy and Diversified Industries, TMX Group, to celebrate the Company’s new listing on Toronto Stock Exchange and open the market.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it is one of the seventeen companies in the U.S. and Canada that will be included in the First Psychedelics Exchange Traded Fund, which is managed by Horizons ETF Management.

The Horizons Psychedelic Stock Index ETF index is expected to start trading on Tuesday, January 26, under the ticker PSYK on the NEO exchange.

Keep reading... Show less